BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34280400)

  • 1. Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon.
    Teston APM; Fernandes NS; Abegg CP; de Abreu AP; Sarto MPM; Gomes ML; Toledo MJO
    Exp Parasitol; 2021 Sep; 228():108136. PubMed ID: 34280400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of oral infection in mice inoculated with Trypanosoma cruzi IV of the Western Brazilian Amazon.
    Margioto Teston AP; de Abreu AP; Abegg CP; Gomes ML; de Ornelas Toledo MJ
    Acta Trop; 2017 Feb; 166():212-217. PubMed ID: 27876646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.
    Gruendling AP; Massago M; Teston AP; Monteiro WM; Kaneshima EN; Araújo SM; Gomes ML; Barbosa Md; Toledo MJ
    Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon.
    Teston AP; Monteiro WM; Reis D; Bossolani GD; Gomes ML; de Araújo SM; Bahia MT; Barbosa MG; Toledo MJ
    Trop Med Int Health; 2013 Jan; 18(1):85-95. PubMed ID: 23130989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
    Zanusso Junior G; Massago M; Kian D; Toledo MJO
    Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of infection in mice inoculated by the oral route with different developmental forms of Trypanosoma cruzi I and II.
    Dias GB; Gruendling AP; Araújo SM; Gomes ML; Toledo MJ
    Exp Parasitol; 2013 Nov; 135(3):511-7. PubMed ID: 23994765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
    Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
    Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pathogenicity in Swiss mice of Trypanosoma cruzi IV from northern Brazil and Trypanosoma cruzi II from southern Brazil.
    Meza SK; Kaneshima EN; Silva Sde O; Gabriel M; de Araújo SM; Gomes ML; Monteiro WM; Barbosa Md; Toledo MJ
    Exp Parasitol; 2014 Nov; 146():34-42. PubMed ID: 25296157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioridazine aggravates skeletal myositis, systemic and liver inflammation in Trypanosoma cruzi-infected and benznidazole-treated mice.
    Mendonça AAS; Gonçalves-Santos E; Souza-Silva TG; González-Lozano KJ; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
    Int Immunopharmacol; 2020 Aug; 85():106611. PubMed ID: 32447223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential oils from Syzygium aromaticum and Zingiber officinale, administered alone or in combination with benznidazole, reduce the parasite load in mice orally inoculated with Trypanosoma cruzi II.
    Sarto MPM; Lucas da Silva HF; de Souza Fernandes N; de Abreu AP; Zanusso Junior G; de Ornelas Toledo MJ
    BMC Complement Med Ther; 2021 Feb; 21(1):77. PubMed ID: 33632196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.
    Oliveira-Silva JC; Machado-de-Assis GF; Oliveira MT; Paiva NC; Araújo MS; Carneiro CM; Martins-Filho OA; Martins HR; Lana Md
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):86-94. PubMed ID: 25742267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.
    Caldas IS; Talvani A; Caldas S; Carneiro CM; de Lana M; da Matta Guedes PM; Bahia MT
    Parasitol Res; 2008 Jul; 103(2):413-21. PubMed ID: 18454349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
    Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of combined therapy with amiodarone and low-dose benznidazole in a mouse model of chronic Trypanosoma cruzi infection.
    Barbosa JMC; Pedra-Rezende Y; Mata-Santos HA; Vilar-Pereira G; Melo TG; Ramos IP; Gibaldi D; Moreira OC; Nunes DF; Batista MM; Lannes-Vieira J; Daliry A; Salomão K
    Biomed Pharmacother; 2024 Jun; 175():116742. PubMed ID: 38754265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
    Santos DM; Martins TA; Caldas IS; Diniz LF; Machado-Coelho GL; Carneiro CM; Oliveira Rde P; Talvani A; Lana M; Bahia MT
    Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benznidazole, itraconazole and their combination in the treatment of acute experimental chagas disease in dogs.
    Cunha ELA; Torchelsen FKVDS; Cunha LM; de Oliveira MT; Fonseca KDS; Vieira PMA; Carneiro CM; de Lana M
    Exp Parasitol; 2019 Sep; 204():107711. PubMed ID: 31254494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
    Fernández MC; González Cappa SM; Solana ME
    Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.
    Strauss M; Rodrigues JHS; Lo Presti MS; Bazán PC; Báez AL; Paglini-Oliva P; Nakamura CV; Bustamante JM; Rivarola HW
    Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
    Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.